#USA #Jacksonville #Wound Care #Healogics #John P. Landino

Healogics Welcomes John P. Landino as Chief Development Officer

Healogics, renowned for its expertise in advanced wound care and hyperbaric oxygen therapy, has recently celebrated a significant leadership change by appointing John P. Landino as its new Chief Development Officer. This strategic decision comes at a pivotal moment as the company celebrates 30 years in the wound care industry, aiming to enhance its commitment to patient care through innovative partnerships and growth strategies.

A Proven Leader in Healthcare

John Landino is not new to the landscape of healthcare. With nearly two decades of experience in business development, he has an impressive track record in establishing strategic alliances with hospital executives and healthcare leaders. His previous roles at Fresenius Medical Care North America and Tenet Healthcare emphasize his capability in driving business expansion and fostering physician engagement initiatives. Landino’s appointment signals Healogics' intention to harness his expertise for continued growth and enhancement of its services.

In his new role, Landino will oversee the company's growth strategy, actively seeking to create new partnerships and uncover business opportunities that align with Healogics’ mission to transform wound care practices across the country.

Vision for the Future

“I could not be more excited to be part of Healogics, the nation's leading wound care organization,” expressed John. He highlighted the organization's proven history of innovation and impact on patient care, which continues to drive the company's endeavors. With Landino's leadership, Healogics is poised to expand its reach significantly, ensuring that more communities gain access to crucial wound care services and advanced healing technologies.

Pamela Mandel, the Chairman and CEO of Healogics, echoed Landino's sentiments, expressing enthusiasm over his appointment. She stated, “John's extensive experience in healthcare development and his innovative approach make him an ideal leader for our growth initiatives. We are thrilled to welcome him to our executive team, and we look forward to working together as we continue to strengthen our partnerships.”

This change in leadership aligns seamlessly with Healogics’ overarching objective to shape the future of wound care by fostering a healing environment that is evidence-based and patient-centered. The organization is well-known for its commitment to quality care, underpinned by the world's largest wound care outcomes database that informs clinical practices and drives the Wound Science Initiative.

About Healogics

For over 30 years, Healogics has been at the forefront of advanced wound care, collaborating with hospitals and healthcare systems to deliver specialized, effective treatments for patients with chronic wounds. The mission to FIND. TREAT. HEAL.™ reflects not just the company's operational philosophy, but a broader commitment to improving patient outcomes nationwide.

With the appointment of John P. Landino, Healogics is not just marking a new chapter in its leadership but is also reaffirming its dedication to innovation and excellence in the healthcare industry. This leadership transition promises an exciting period for both the organization and its patients as it continues to set new standards for wound care delivery and outcomes.

For more information about Healogics and its initiatives, visit www.healogics.com.